Cytokine and innate immune signaling network

The cytokine and innate immune signaling network is a complex system of proteins and pathways responsible for detecting pathogens and initiating the body's primary defense mechanisms. It involves pattern recognition receptors (PRRs) like Toll-like receptors (TLRs) and NOD-like receptors (NLRs) that sense microbial components or damage-associated signals (Akira S, et al., 2006, Cell). Upon activation, these receptors trigger intracellular cascades, such as the NF-κB and JAK-STAT pathways, leading to the production of pro-inflammatory cytokines and interferons (O'Shea JJ, et al., 2013, Science). This network plays a critical role in orchestrating the inflammatory response and bridging innate and adaptive immunity (Janeway CA Jr, et al., 2001, Immunobiology). Dysregulation of these pathways is central to the pathogenesis of autoimmune diseases, chronic inflammation, and cytokine release syndromes (Dinarello CA, 2007, Eur J Immunol). Therapeutic strategies often involve monoclonal antibodies or small molecules that target specific nodes within this network, such as Tumor necrosis factor-alpha or Janus kinases, to restore immune homeostasis (Kulas J, et al., 2021, Front Pharmacol). The network also includes the inflammasome, a multiprotein complex that mediates the release of highly pro-inflammatory cytokines like Interleukin-1 beta (Latz E, et al., 2013, Nat Rev Immunol). Understanding the crosstalk between different signaling nodes is essential for developing precision therapies that minimize off-target immunosuppression.

Other names

Innate immune signalingCytokine signaling pathwayInflammatory signaling networkInnate immune system signaling

Drugs targeting this network function by neutralizing pro-inflammatory cytokines, blocking their respective receptors, or inhibiting intracellular signaling transducers such as Janus kinases (JAKs) to prevent gene transcription associated with inflammation (O'Shea JJ, et al., 2013, Science).